Extract from the Register of European Patents

EP About this file: EP3663387

EP3663387 - DEVICE AND METHOD FOR TREATING FLUIDS, PARTICULARLY BODY FLUIDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2024
Database last updated on 19.03.2026
FormerThe patent has been granted
Status updated on  28.07.2023
FormerGrant of patent is intended
Status updated on  14.03.2023
FormerExamination is in progress
Status updated on  28.01.2021
FormerRequest for examination was made
Status updated on  08.05.2020
Most recent event   Tooltip13.03.2026Lapse of the patent in a contracting state
New state(s): HU
published on 15.04.2026 [2026/16]
Applicant(s)For all designated states
Bruker Daltonics GmbH & Co. KG
Fahrenheitstraße 4
28359 Bremen / DE
[2021/47]
Former [2020/24]For all designated states
Bruker Daltonik GmbH
Fahrenheitstrasse 4
28359 Bremen / DE
Inventor(s)01 / Becker, Karsten
Wibbeltweg 9
48366 Laer / DE
02 / Idelevich, Evgeny
Einsteinstraße 22
48149 Münster / DE
 [2020/24]
Representative(s)Boßmeyer, Jens
Bruker Daltonics GmbH & Co. KG
Fahrenheitstraße 4
28359 Bremen / DE
[2023/35]
Former [2020/24]Boßmeyer, Jens
Bruker Daltonik GmbH
Fahrenheitstraße 4
28359 Bremen / DE
Application number, filing date20152089.728.07.2016
[2020/24]
Priority number, dateDE20151011234329.07.2015         Original published format: DE102015112343
[2020/24]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP3663387
Date:10.06.2020
Language:DE
[2020/24]
Type: B1 Patent specification 
No.:EP3663387
Date:30.08.2023
Language:DE
[2023/35]
Search report(s)(Supplementary) European search report - dispatched on:EP04.03.2020
ClassificationIPC:A61B5/15, C12Q1/04, C12M1/12, C12Q1/24, B01L3/00, G01N1/40, G01N33/49, A61B5/153, C12M1/00
[2023/13]
CPC:
C12Q1/04 (EP,US); C12M23/00 (CN); A61B5/15003 (EP);
A61B5/150236 (EP); A61B5/150251 (EP); A61B5/150755 (EP);
A61B5/153 (EP); B01D29/01 (CN); B01D29/58 (CN);
B01L3/502 (EP,US); C12M23/04 (CN); C12M23/10 (CN);
C12M23/38 (CN); C12M23/44 (CN); C12M23/52 (CN);
C12M27/10 (CN); C12M33/04 (CN,US); C12M33/14 (CN,US);
C12M37/02 (CN); C12M41/12 (CN); C12M43/00 (CN);
C12M47/04 (US); C12Q1/24 (EP,US); G01N1/4077 (EP,US);
B01L2200/141 (US); B01L2300/0681 (EP,US); B01L2400/0478 (EP,US);
B01L2400/0605 (EP,US); C12M25/02 (US); C12M47/02 (EP,US);
G01N2001/4088 (EP,US); G01N33/491 (EP,US) (-)
Former IPC [2020/24]C12M1/12, C12Q1/04, C12Q1/24, G01N33/49, B01L3/00, G01N1/40
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/24]
TitleGerman:VORRICHTUNG UND VERFAHREN ZUM AUFBEREITEN VON FLÜSSIGKEITEN, INSBESONDERE KÖRPERFLÜSSIGKEITEN[2020/24]
English:DEVICE AND METHOD FOR TREATING FLUIDS, PARTICULARLY BODY FLUIDS[2020/24]
French:DISPOSITIF ET PROCÉDÉ DE TRAITEMENT DE LIQUIDES, NOTAMMENT DE LIQUIDES CORPORELS[2020/24]
Examination procedure31.01.2020Examination requested  [2020/24]
27.01.2021Despatch of a communication from the examining division (Time limit: M02)
10.03.2021Reply to a communication from the examining division
08.04.2022Despatch of a communication from the examining division (Time limit: M04)
24.06.2022Reply to a communication from the examining division
15.03.2023Communication of intention to grant the patent
11.07.2023Receipt of the translation of the claim(s)
12.07.2023Fee for grant paid
12.07.2023Fee for publishing/printing paid
Parent application(s)   TooltipEP16756594.4  / EP3328987
Opposition(s)03.06.2024No opposition filed within time limit [2024/32]
Fees paidRenewal fee
31.01.2020Renewal fee patent year 03
31.01.2020Renewal fee patent year 04
23.07.2020Renewal fee patent year 05
26.07.2021Renewal fee patent year 06
27.07.2022Renewal fee patent year 07
26.07.2023Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY28.07.2016
HU28.07.2016
BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
[2026/16]
Former [2026/10]CY28.07.2016
BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2025/11]BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
MC30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/51]BG30.08.2023
CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/36]CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SI30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/23]CZ30.08.2023
DK30.08.2023
EE30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
PT02.01.2024
Former [2024/22]CZ30.08.2023
DK30.08.2023
FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SE30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/20]FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/14]FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
NL30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/10]FI30.08.2023
HR30.08.2023
LT30.08.2023
LV30.08.2023
PL30.08.2023
RS30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/09]FI30.08.2023
LT30.08.2023
SE30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/08]LT30.08.2023
NO30.11.2023
GR01.12.2023
Documents cited:Search[A] US2011100921  (HEINRICH HANS-WERNER et al.)
 [A] WO2013000897  (GE HEALTHCARE UK LTD et al.)
 [A] US2014017779  (WAICHE GAEL et al.) [A] 1-15 * figures 1,2; claim 1 *
ExaminationUS4957637
 US3931010
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.